Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

13.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

922
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
922
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.2K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
Drug Therapy01:28

Drug Therapy

400
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
400

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-throughput screening approach identifies substrate-selective Hsp104 variants that counter amyloid seeding with diminished off-target effects.

Molecular cell·2026
Same author

Advancing the conversation: 30 years of scholarship in managed care pharmacy.

Journal of managed care & specialty pharmacy·2025
Same author

Emerging trends in managed care pharmacy: A mixed-method study.

Journal of managed care & specialty pharmacy·2025
Same author

Emerging trends in managed care pharmacy: A mixed-method study.

Journal of managed care & specialty pharmacy·2025
Same author

Concentration of spending and share of specialty drug spending in Medicare Part D over a 10-year period.

Journal of managed care & specialty pharmacy·2024
Same author

Themed issue on drug pricing policy and the Inflation Reduction Act.

Journal of managed care & specialty pharmacy·2024

Related Experiment Video

Updated: Mar 27, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K

Using sequence discovery to target outreach for diabetes medication adherence.

April Lopez1, Charron Long, Laura E Happe

  • 1500 W Main St, Louisville, KY 40202.

The American Journal of Managed Care
|January 7, 2016
PubMed
Summary

Sequence discovery identified key events preceding diabetes medication refill gaps. Targeted outreach based on these sequences can improve medication adherence for patients.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K

Related Experiment Videos

Last Updated: Mar 27, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K

Area of Science:

  • Health Services Research
  • Data Science
  • Pharmacoeconomics

Background:

  • Medication non-adherence is a significant challenge in managing chronic diseases like diabetes.
  • Identifying patterns preceding prescription refill gaps is crucial for developing effective interventions.
  • Health plans seek strategies to improve patient adherence and reduce associated healthcare costs.

Purpose of the Study:

  • To identify specific sequences of patient exposures that correlate with gaps in diabetes medication refills.
  • To pinpoint opportunities for health plans to implement targeted outreach for enhancing medication adherence.

Main Methods:

  • Utilized sequence discovery techniques to analyze patient data and identify preceding exposure sequences.
  • Defined therapy gaps as a prescription refill obtained 6 or more days after the previous supply.
  • Analyzed 90-day exposure sequences prior to refill gaps or the last refill date for comparison.

Main Results:

  • Identified three high-opportunity sequences for intervention in patients with diabetes medication gaps.
  • Sequence 1: New medication prescription, especially with out-of-network claims or specialist visits.
  • Sequence 2: Reversed prescription claims, followed by new prescriptions or specialist visits.
  • Sequence 3: Multiple out-of-network claims combined with a hospitalization.

Conclusions:

  • Novel application of sequence discovery effectively identified unique event sequences linked to medication refill gaps.
  • These identified sequences offer specific, actionable opportunities for targeted patient outreach to improve adherence.
  • Addressing these critical junctures can lead to better diabetes management and health outcomes.